Clinical Reserrch On Banxiabaizhutianma Decoction Added And Subtracted In Treating The Residual Symptoms Of Successful PC-BPPV Reconstruction

PurposeBy observing the score of DHI(Vertigo Disability scale),VAS(Visual analogue)and the change of TCM symptom score,to investigate the clinical effect of Banxiabaizhutianma decoction added and subtracted compared with betahistine mesylate on residual symptoms of benign paroxysmal positional vertigo of posterior semicircular canal due to phlegm turbid obstruction.MethodsSixty patients eligible for the subject from January 2018 to December 2018 were randomly divided into the observation group(30 cases)and the control group(30 cases).The control group was given betahistine mesylate 6 mg,3 times a day;the observation group was treated with Banxiabaizhutianma decoction added and subtracted,1 dose per day,morning and evening temperature for 1 second after meal 30 min,the course of treatment was 14 days.The DHI scale,VAS score,TCM syndrome score and the effect of treatment were observed in the two groups in the study day,7 days after treatment,14 days after treatment,to evaluate the clinical effect of Banxiabaizhutianma decoction added and subtracted in the treatment of benign paroxysmal positional vertigo of posterior semicircular canal due to phlegm turbid obstructionon.Results1.There were no significant differences between the two groups in sex,age,cause of onset,duration of disease before reduction,times of Epley manual reduction,DHI scale,VAS score and TCM symptom score(P>0.05).2.In the observation group,the scores of DHI(total score,E score,F score,P score),VAS score,TCM symptom score were significantly lower than those before 7 and 14 days after treatment,the difference was statistically significant(P<0.05).In the control group,the scores of DHI(total score,F score,P score),VAS score and TCM symptom score decreased significantly after 7 days and 14 days of treatment(P<0.05),after 7 days of treatment,there was no significant decrease in E score of DHI scale compared with that before treatment(P>0.05),but after 14 days of treatment,the difference was statistically significant(P<0.05).The scores of DHI(total score,E score,F score),VAS score and TCM symptom score in the observation group were lower than those in the control group after 7 days and 14 days of treatment,and the difference was statistically significant(P<0.05),there was no significant difference in P score of DHI scale at the same treatment time(P>0.05).3.Clinical efficacy analysis,7 days after treatment,the effective rate in the observation group was significantly higher than that in the control group.In the observation group,3 cases were cured,6 cases were obviously effective,12 cases were effective and 9 cases were ineffective.And the total effective rate was 70%.In the control group,1 case was cured,3 cases were markedly effective,9 cases were effective and 17 cases were ineffective,the total effective rate was 43.3%.14 days after treatment,the effective rate in the observation group was significantly higher than that in the control group: in the observation group,8 cases were cured,12 cases were obviously effective,7 cases were effective,3 cases were ineffective,and the total effective rate was 90%.In the control group,4 cases were cured,8 cases were markedly effective,11 cases were effective and 7 cases were ineffective,the total effective rate was 76.7%.There was significant difference of treatment effect between two group(P<0.05).ConclusionBanxiabaizhutianma decoction added and subtracted can significantly reduce the DHI score(total score,E score,F score),VAS score and vertigo TCM symptom score in patients with residual symptoms after successful reduction of PC-BPPV in phlegm turbidity compared with betahistine mesylate,as far as the P score of DHI scale was concerned,the two treatment methods had the same effect on the improvement of body function of the patients.Banxiabaizhutianma decoction added and subtracted can reduce vertigo,improve anxiety and depression,and improve the quality of life.